- Role
- Country
- Date of registration
- Address
ES-MF-000000784Anti-Lea Mono-Type is an EU IVDR-regulated in vitro diagnostic registered in EUDAMED. It is classified as IVDR Class C. Manufactured by Diagnostic Grifols, S.A.. Placed on the EU market in Spain. Explore certificates, regulatory status and the EUDAMED record on MD Atlas.
EUDAMED last updated this device on Jan 29, 2026
843658373ANTISERA012GSPrimary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
(01)08436583731543
The compliance carrier: encodes the device identifier plus the production identifiers (lot, serial, dates) registered for this device.
Sterile
A sterile device is supplied free of viable micro-organisms — flagged so that it is handled, stored and used to preserve that sterile state.
Single-use device
A single-use device is intended to be used on one patient during a single procedure and then discarded — not reprocessed or reused.
Primary placement in Spain; available across 32 countries total.
| Country | On market since | Until |
|---|---|---|
| SpainPrimary placement | Dec 5, 2025 | Still on market |
| Austria | Dec 5, 2025 | Still on market |
| Belgium | Dec 5, 2025 | Still on market |
| Bulgaria | Dec 5, 2025 | Still on market |
| Cyprus | Dec 5, 2025 | Still on market |
| Czechia | Dec 5, 2025 | Still on market |
| Germany | Dec 5, 2025 | Still on market |
| Denmark | Dec 5, 2025 | Still on market |
| Estonia | Dec 5, 2025 | Still on market |
| EL | Dec 5, 2025 | Still on market |
| Finland | Dec 5, 2025 | Still on market |
| France | Dec 5, 2025 | Still on market |
| Croatia | Dec 5, 2025 | Still on market |
| Hungary | Dec 5, 2025 | Still on market |
| Ireland | Dec 5, 2025 | Still on market |
| Iceland | Dec 5, 2025 | Still on market |
| Italy | Dec 5, 2025 | Still on market |
| Liechtenstein | Dec 5, 2025 | Still on market |
| Lithuania | Dec 5, 2025 | Still on market |
| Luxembourg | Dec 5, 2025 | Still on market |
| Latvia | Dec 5, 2025 | Still on market |
| Malta | Dec 5, 2025 | Still on market |
| Netherlands | Dec 5, 2025 | Still on market |
| Norway | Dec 5, 2025 | Still on market |
| Poland | Dec 5, 2025 | Still on market |
| Portugal | Dec 5, 2025 | Still on market |
| Romania | Dec 5, 2025 | Still on market |
| Sweden | Dec 5, 2025 | Still on market |
| Slovenia | Dec 5, 2025 | Still on market |
| Slovakia | Dec 5, 2025 | Still on market |
| Türkiye | Dec 5, 2025 | Still on market |
| XI | Dec 5, 2025 | Still on market |
Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
08436583731543Basic UDI-DI
The Basic UDI-DI is the main identifier that groups together all device variants of the same model — the regulatory "family" key.
843658373ANTISERA012GS210927UDI issuing entities
Issuing entities are the organisations the European Commission has designated to assign Unique Device Identifiers under the EU's UDI system.
IVDR risk classes
IVDR risk classes rank in-vitro diagnostic devices from lowest risk (Class A) to highest (Class D), based on the patient and public-health risk of a wrong result.
European Medical Device Nomenclature — the EU product classification assigned to this device.
W0103030501OTHER ANTIGEN TYPING REAGENTSNo certificate specifically references this device's Basic UDI-DI.
No certificates registered for this manufacturer.
No certificate references this Basic UDI-DI, because: • It does not require a certificate, or • It only requires a certificate without a Basic UDI-DI reference (e.g. a QMS certificate), or • The required certificate(s) referencing this Basic UDI-DI have not been registered yet.843658373ANTISERA016H2On the marketAnti-H for DG Gel843658373ANTISERA018H6On the marketAnti-H Mono-Type843658373ANTISERA017H4On the marketAnti-Leb Mono-Type843658373ANTISERA013GUOn the marketBlood Typing Manager843658373BTMRPOn the marketBlood Typing Manager843658373BTM001GVOn the market